Product correctly added to cart.

discount label
Erlotinib
View 3D

Targetmol logo

Erlotinib

CAS: 183321-74-6

Ref. TM-T0373

50mg
47.00 €
100mg
52.00 €
500mg
78.00 €
1ml*10 (DMSO)
54.00 €
Estimated delivery in United States, on Thursday 11 Apr 2024

Product Information

Name:
Erlotinib
Synonyms:
  • OSI-744, NSC 718781, CP358774, R1415
  • 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
  • 4-[(3-Ethynylphenyl)Amino]-6,7-Bis(2-Methoxyethoxy)Quinazoline
  • Erlotinib & its intermediates (Developing)
  • Erlotinib Base
  • Erlotinin
  • N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
  • N-(3-Ethynylphenyl)[6,7-Bis(2-Methoxyethoxy)Quinazolin-4-Yl]Amine
  • NSC 718781
  • Osi 744
  • See more synonyms
  • R 1415
Description:

Erlotinib (NSC-718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.

Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
393.44
Formula:
C22H23N3O4
Purity:
99.98%
Color/Form:
White To Off-White Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T0373 Erlotinib

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!Please accept the use of cookies to have a better experience on our website.

Cookies are important for you, they influence your browsing experience, they help us to protect your privacy and allow us to proceed with the requests that you demand through this website. We use our own and third-party cookies to analyze our services. If you consent to its installation, click on "Accept", otherwise click on "Reject". You can also set your preferences by clicking "Settings". More information is available in our Cookies Policy.